Author:
Ma Yanyan,Liu Liwen,Yuan Lijun,Lee Alex Pui-Wai
Reference17 articles.
1. Crossen K, Jones M, Erikson C. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy. Heart Rhythm. 2016;13:1885–90.
2. Honghu W, Dawei W. Coronary CTA in the hypertrophic heart disease patients with angina pectoris in application value. Chin J CT and MRI. 2016;14:64–8.
3. Tian L, Shihua Z, Minjie L. Contrast-enhanced cardiovascular magnetic resonance imaging for differentiating the patients with ischemic heart disease and primary dilated cardiomyopathy. Chin Circ J. 2014;(29):284–7.
4. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (esc). Eur Heart J. 2014;35:2733–79.
5. American College of Cardiology Foundation/American Heart Association Task Force on Practice G, American Association for Thoracic S, American Society of E, American Society of Nuclear C, Heart Failure Society of A, Heart Rhythm S, Society for Cardiovascular A, Interventions, Society of Thoracic S, Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Thorac Cardiovasc Surg. 2011;142:1303–38.